Development and validation of a nomogram (APGRC) to predict the presence of germline DNA damage repair pathogenic variants in Asian patients with prostate cancer

Clin Transl Med. 2023 Sep;13(9):e1411. doi: 10.1002/ctm2.1411.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • DNA Damage / genetics
  • Germ Cells
  • Humans
  • Male
  • Nomograms*
  • Prostatic Neoplasms* / diagnosis
  • Prostatic Neoplasms* / genetics